Risk of dementia after fluctuating mild cognitive impairment : When the yo-yoing stops

Neurology

Volumn 82, Issue 4, 2014, Pages 290-291

  Zonderman, Alan B ^a   Dore, Gregory A ^a  

^a Biomedical Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E EPSILON 4; UNCLASSIFIED DRUG;

ALLELE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; COGNITION; COGNITIVE RESERVE; DEMENTIA; DISEASE ASSOCIATION; EDITORIAL; GENETIC RISK; HUMAN; MILD COGNITIVE IMPAIRMENT; PRIORITY JOURNAL; PSYCHOMOTOR PERFORMANCE; RISK FACTOR;

DEMENTIA; DISEASE PROGRESSION; HUMANS; MILD COGNITIVE IMPAIRMENT; RISK FACTORS;

EID: 84895736965     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000000065     Document Type: Editorial

References (4)

1. Roberts RO, Knopman DS, Mielke MM, et al. Higher risk of progression to dementia in mild cognitive impairment cases who revert to normal. Neurology 2014;82:317-325.
2. Gamaldo AA, An Y, Allaire JC, Kitner-Triolo MH, Zonderman AB. Variability in performance: Identifying early signs of future cognitive impairment. Neuropsychology 2012;26:534-540.
3. Smith JC, Nielson KA, Antuono P, et al. Semantic memory functional MRI and cognitive function after exercise intervention in mild cognitive impairment. J Alzheimers Dis 2013;37:197-215.
4. Bu G. Apolipoprotein E and its receptors in Alzheimer's disease: Pathways, pathogenesis and therapy. Nat Rev Neurosci 2009;10:333-344.